UK MHRA seeks feedback on vigilance system for breast implants
This article was originally published in RAJ Devices
Executive Summary
The UK’s Medicines and Healthcare products Regulatory Agency has issued draft guidance advising manufacturers of CE-marked breast implants on how to report adverse events involving their products under the Medical Devices Vigilance System1.